HWAM
FLNA

Hennion & Walsh Asset Management’s Filana Therapeutics FLNA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,517
Closed -$663K – 902
2024
Q3 		$663K Sell
22,517
-2,364
-10% -$54.4K 0.03% 552
2024
Q2 		$307K Sell
24,881
-211
-0.8% -$4.45K 0.02% 720
2024
Q1 		$509K Buy
25,092
+3,151
+14% +$72.6K 0.03% 560
2023
Q4 		$494K Sell
21,941
-307
-1% -$6.49K 0.03% 552
2023
Q3 		$370K Buy
22,248
+1,605
+8% +$31.8K 0.02% 604
2023
Q2 		$506K Buy
20,643
+409
+2% +$9.85K 0.03% 503
2023
Q1 		$488K Buy
20,234
+3,434
+20% +$95.1K 0.03% 510
2022
Q4 		$496K Buy
+16,800
New +$604K 0.03% 505

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Hennion & Walsh Asset Management's FLNA Position: Q4 2024 in Review

Hennion & Walsh Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 22,517 shares — an estimated $663K sold.

Hennion & Walsh Asset Management first reported a position in FLNA in Q4 2022 and held it in 8 quarters. The position peaked at $663K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Hennion & Walsh Asset Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 22,517 Filana Therapeutics shares in Q4 2024, an estimated $663K.
  • Hennion & Walsh Asset Management first reported a position in Filana Therapeutics in Q4 2022 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Filana Therapeutics position peaked at $663K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.